EQUITY RESEARCH MEMO
ForSight Robotics
Generated 6/11/2026
Executive Summary
Conviction (model self-assessment)75/100
ForSight Robotics is a privately held ophthalmic medical device company headquartered in Yokneam Illit, Israel, founded in 2020. The company has developed the JASPER™ Robotic Surgery Platform, an AI-driven, high-precision system designed to enhance cataract surgery and other ophthalmic procedures. JASPER combines micron-level robotic control, 3D intra-operative imaging, and real-time data analytics to improve surgeon performance and patient outcomes. With $125 million in total funding, the company is progressing through the platform development stage and targeting a significant market opportunity in the aging global population requiring cataract surgery.
Upcoming Catalysts (preview)
- Q2 2027FDA 510(k) clearance for JASPER platform65% success
- Q4 2026Pivotal clinical trial data readout70% success
- Q3 2026Strategic partnership with a major ophthalmic company50% success
Locked sections
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)